The Methodological Issues of Using Cross-Sectional Data for Pharmaceutical Health Outcome Analysis

Sharyn Lymer, Laurie Brown

    Research output: Working paperDiscussion paper


    This paper looks at the use of cross-sectional data in pharmaceutical health outcomes
    research. NATSEM attempted cutting edge research on health outcomes using the
    NATSEM-Medicines Australia MedSim basefile. The results from this analysis are
    not robust and are generally quite problematic. The key limitation is that in using
    cross-sectional data it was not able to show that the groups being compared were the
    same except for the use of medications. For future work, it may be preferable to
    explore health outcomes using longitudinal patient level data (for the Australian
    Original languageEnglish
    Place of PublicationCanberra
    Number of pages42
    ISBN (Print)1740882512
    Publication statusPublished - 2006


    Cite this